Global seroprevalence of SARS-CoV-2 antibodies: A systematic review and meta-analysis.

Niklas Bobrovitz Rahul Krishan Arora Christian CaoEmily BoucherMichael LiuClaire DonniciMercedes Yanes-LaneMairead WhelanSara Perlman-ArrowJudy ChenHannah RahimNatasha IlincicMitchell SegalNathan DuarteJordan Van WykTingting YanAustin AtmajaSimona RoccoAbel JosephLucas PennyDavid A CliftonTyler WilliamsonCedric P YansouniTimothy Grant EvansJonathan ChevrierJesse PapenburgMatthew P Cheng

Published in: PloS one (2021)

Most of the population remains susceptible to SARS-CoV-2 infection. Public health measures must be improved to protect disproportionately affected groups, including racial and ethnic minorities, until vaccine-derived herd immunity is achieved. Improvements in serosurvey design and reporting are needed for ongoing monitoring of infection prevalence and the pandemic response.

Keyphrases

sars cov
public health
respiratory syndrome coronavirus
risk factors
coronavirus disease
adverse drug
african american